25 March 2022
For immediate release
The information contained in this announcement is restricted and is not for publication, release or distribution in
Pantheon International Plc
("PIP" or the "Company")
Performance Update at 28 February 2022
Performance Update at 28 February 2022
417.6p NAV per share
+1.3% NAV per share movement for the month
4.0x Financing cover**
+77% Total shareholder return (5Y)***
Month to 28 February 2022
PIP announced an unaudited net asset value ("NAV") per share as at 28 February 2022 of 417.6p, an increase of 5.3p (+1.3%) from the NAV per share as at 31 January 2022.
In the month to 28 February 2022, valuation gains* were +5.4p (+1.3%), investment income* added +0.1p (+0.0%), foreign exchange movements* were +0.3p (+0.1%) and expenses and taxes**** were -0.5p (-0.1%).
The NAV per share as at 28 February 2022 reflects a mark to market fair value adjustment for listed company holdings. Companies that are now publicly listed comprised c.13% of PIP's portfolio value as at 28 February 2022.
Pantheon is monitoring the tragic events in
PIP's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which PIP has holdings. In the case of PIP's valuation as at 28 February 2022, 15% of reported valuations are dated 28 February 2022, 47% are dated 31 December 2022 and 38% are dated 30 September 2021.
At 28 February 2022, PIP's private equity assets stood at
During the month, PIP made a new primary commitment of
PIP's pipeline points to an active period for new commitments in the coming months, especially for co-investments and single-asset secondaries.
Nine months to 28 February 2022
Performance
The unaudited NAV per share at 28 February 2022 of 417.6p is an increase of +72.8p (+21.1%) relative to the NAV per share at 31 May 2021. Valuation gains* added +60.9p (+17.6%), investment income* added +2.7p (+0.8%), foreign exchange movements* were +13.6p (+3.9%), share buybacks added +0.2p (+0.1%) and expenses and taxes**** were -4.6p (-1.3%).
Portfolio Net Cash Flow
PIP's portfolio generated net cash of
New Commitments
PIP made 53 new investments in the nine months to 28 February 2022, amounting to
PIP invested in 19 primaries (
*Figures are stated net of movements associated with the ALN share of the reference portfolio.
**Ratio of net available cash, portfolio value and undrawn loan facility to outstanding commitments.
***Based on the change in the ordinary share price over the period.
****Withholding taxes on investment distributions.
^Net available cash calculated as cash and net current assets / (liabilities) less undistributed net cashflows associated with the ALN.
^^Unlisted 10-year note issued on 31 October 2017 whose cost and repayments are linked to a reference portfolio consisting of the Company's older vintage funds.
Share Buybacks
PIP invested
Performance as at 28 February 2022^^^
|
1 Year (%p.a.) |
3 Years (% p.a.) |
5 Years (% p.a.) |
10 Years (% p.a.) |
Since Inception (% p.a.)
|
|
||
NAV TR per share |
32.4% |
18.1% |
14.8% |
13.9% |
12.2% |
|||
Ordinary share price |
24.6% |
12.9% |
12.0% |
15.3% |
11.4% |
|||
FTSE All-Share TR |
16.0% |
5.8% |
4.7% |
6.9% |
7.5% |
|||
MSCI World (£) TR |
15.9% |
14.7% |
11.0% |
13.3% |
8.4% |
|||
^^^PIP was launched on 18 September 1987. The performance figures for PIP assume reinvestment of dividends, capital.
Largest Holdings
Largest managers by value as at 28 February 2022
|
Region |
% of portfolio |
1 Insight Partners |
|
8.3% |
2 Index Ventures |
Global |
5.3% |
3 Providence Equity Partners |
|
3.4% |
4 Essex Woodlands |
|
3.0% |
5 Advent International Group |
Global |
2.6% |
Largest companies by value as at 30 September 2021µ
|
Country |
Sector |
% of portfolio |
1 EUSA Pharmaα |
|
Healthcare |
2.4% |
2 Chewy |
|
Consumer |
1.0% |
3 Visma |
|
Information Technology |
0.9% |
4 Mural |
|
Information Technology |
0.9% |
5 Asurion |
|
Financials
|
0.9% |
µBased on valuations as at 30 September 2021 adjusted for known calls and distributions to 30 November 2021, and accounts for 100% of PIP's portfolio.
αThe valuation for EUSA Pharma has been adjusted to reflect the agreed sales price for the company. The exit transaction completed on 16 March 2022 and the proceeds will be reflected in the March reporting period.
Foreign Exchange Exposure
At 28 February 2022, the value of the private equity investment assets stood at
In addition to the funds reporting values denominated in sterling, many of the euro-denominated funds have investments in the
As at 28 February 2022, the GBP/USD exchange rate was GBP/USD exchange rate was 1.3419 and the GBP/EUR exchange rate was 1.1946.
Monthly Report
The February monthly newsletter can be accessed on PIP's website at www.piplc.com in the Investor Relations section under the heading "Newsletters".
This announcement contains inside information.
Ends
LEI: 2138001B3CE5S5PEE928
For more information please visit PIP's website at www.piplc.com or contact:
Pantheon
Helen Steers / Vicki Bradley
020 3356 1800
Follow us on LinkedIn: https://www.linkedin.com/company/pantheon-international-plc
NOTES
PIP
PIP is a listed FTSE 250 private equity investment trust, overseen by an independent Board of Directors and managed by Pantheon, one of the leading private equity investment managers globally. PIP offers investors a liquid, differentiated entry point to the excellent growth potential of global private equity, with access to the primary, secondary and co-investment opportunities of some of the best managers in the world. The Company has a track record of outperformance and manages risk through diversification and rigorous selection based on Pantheon's extensive experience and international platform.
Pantheon
PIP is managed and advised by Pantheon, a leading global private equity, infrastructure & real assets and private debt investor with more than 35 years' experience sourcing and executing private market investment opportunities on behalf of clients. Pantheon has
^^This figure includes assets subject to discretionary or non-discretionary management, advice or those limited to a reporting function.
Important Information
A copy of this announcement will be available on the Company's website at www.piplc.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.
Sir Laurie Magnus CBE
Chairman, Pantheon International Plc
Beaufort House, 51 New North Road,